Publication | Closed Access
Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist
37
Citations
35
References
2021
Year
Metabolic SyndromeMedicinePhysiologyDiabetesType 2Glucose HomeostasisMetabolic RegulationSelective Fxr AntagonistDiabetes MellitusEndocrinologyPharmacologyGastrointestinal Peptide HormoneHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1